Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib.
Lung Cancer. 2020 Mar;141:114-118. doi: 10.1016/j.lungcan.2019.10.021. Epub 2019 Nov 25.
Lung Cancer. 2020.
PMID: 31839416
Free PMC article.